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Peanut allergy is an important health concern among many individuals. As there is no
effective treatment to peanut allergy, continuous monitoring of peanut-based products,
and their sources is essential. Precise detection of peanut allergens is key for identification
and development of improved peanut varieties with minimum or no allergens in addition
to estimating the levels in peanut-based products available in food chain. The antibody
based ELISA protocol along with sample preparation was standardized for Ara h 1, Ara h
2, Ara h 3, Ara h 6, and Ara h 8 to estimate their quantities in peanut seeds. Three different
dilutions were optimized to precisely quantify target allergen proteins in peanut seeds
such as Ara h 1 (1/1,000, 1/2,000, and 1/4,000), Ara h 2 and Ara h 3 (1/5,000, 1/10,000,
and 1/20,000), Ara h 6 (1/40,000, 1/80,000, and 1/1,60,000), and Ara h 8 (1/10, 1/20,
and 1/40). These dilutions were finalized for each allergen based on the accuracy of
detection by achieving <20% coefficient of variation in three technical replicates. This
protocol captured wide variation of allergen proteins in selected peanut genotypes for
Ara h 1 (77–46,106µg/g), Ara h 2 (265–5,426µg/g), Ara h 3 (382–12,676µg/g), Ara h
6 (949–43,375µg/g), and Ara h 8 (0.385–6µg/g). The assay is sensitive and reliable in
precise detection of five major peanut allergens in seeds. Deployment of such protocol
allows screening of large scale germplasm and breeding lines while developing peanut
varieties with minimum allergenicity to ensure food safety.
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INTRODUCTION
Food allergies have become the most important food safety concerns around the world. The
prevalence of food allergy is more in North America, where 6% of young children and 4% of
adults suffer from food allergies (1). Among all the food allergies, ∼1.4% of Americans and 3%
Australian are allergic to peanuts and peanut-based products (2, 3). Peanut allergy is very severe
and sometimes causes death due to anaphylaxis (4, 5). It is reported that food allergies cause
approximately 150 to 200 fatalities per year, based on data from a five year study of anaphylaxis in
Minnesota from the Mayo Clinic. Fatal food anaphylaxis is most often caused by peanuts (50–62%)
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and tree nuts (15–30%) (6). Proteins are the major cause of food
allergy and these allergenic proteins are usually highly resistant
to heat and proteolysis (7). Peanut is the largest source for the
IgE-mediated food allergies among eight major sources namely
tree nuts, egg, cow’s milk, fish, crustacean shellfish, soybean, and
wheat. There is no effective treatment to peanut allergy and the
allergic person is advised strictly to avoid consuming peanut
or peanut-based products (8). Peanut being a common food
ingredient in many food preparations, it is very challenging for
the allergic person to know the composition of these preparations
to avoid consumption (9). The threshold of allergen levels differ
among the allergic population and even a minute dose of 100 µg
of Ara h 1 can trigger an allergic reaction (10). The diagnosis
of peanut allergy can be done using different methods such as
double-blind, placebo-controlled food challenge (DBPCFC), the
basophil activation test, the specific skin prick test (SPT), and the
measurement of specific IgE (11–13).
Of the 32 different types of proteins present in peanut seeds,
16 of these proteins show allergenic property (14). Further, out
of these 16 peanut allergen proteins, Ara h 1, 2, 3, and 6 are
considered as major allergens because they are recognized by the
IgE of a majority of allergic patients. Ara h 5, 7, 8, 9, 10, 11,
and 12/13 are considered minor allergens and are not thought
to be the causative agents in most of the life-threatening allergic
reactions (anaphylaxis) (15). Nevertheless, if a person is already
sensitive to Bet v 1 allergey caused due to birch pollen, then one of
these minor peanut allergens, Ara h 8, shows cross-reactivity with
IgE antibodies causing oral allergy syndrome (OAS) (16–18).
Allergic protein belongs to different protein families namely
cupin (vicilin-type, 7S globulin, legumin-type, 11S globulin,
glycinin), conglutin (2S albumin), profilin, nonspecific lipid-
transfer protein 1, pathogenesis-related protein, PR-10, 14 kDa
oleosin, and 16 kDa oleosin (19), particularly, Ara h 1, Ara h
2, Ara h 3, and Ara h 6 are the seed storage proteins. Many
studies showed that Ara h 1 and Ara h 3 are abundant peanut
proteins but, Ara h 2 and Ara h 6 strongly bind with IgE from
peanut allergic patient and release mediators from basophils,
which confirmed that both are the most important allergens
in vitro (20–23) and in vivo (21, 24, 25) with regards to food
allergy (23). Due to the fact that both Ara h 2 and Ara h 6 are
recognized more prominently and more frequently than Ara h 1
and Ara h 3 by peanut allergic children with almost all of them
showing IgE reactivity to these two allergens (26).
Immuno-assays are the most commonly preferred analytical
techniques being used to detect the food allergens in many
industries (27). Food industries commonly use ELISA to detect
and quantify hidden allergens in food commodities as it is easy
and less time-consuming technique (28–30). Further ELISA is
highly sensitive, reliable, cost-effective, and accurate. In the past
ELISA has been successfully used to detect allergens in several
food products such as in meat and meat products, milk and milk
products, fish and fish products, soybean, nuts and nut-based
products, and fruit juices and their ingredients (31, 32). In ELISA,
allergens can be detected by the colorimetric reaction after
binding of the antigen with the specific enzyme-labeled antibody.
Earlier studies reported the allergenic proteins quantification
in peanut-based products through ELISA and HPLC technique
(29, 33–35), however, no information on peanut seeds. The key
issues in ELISA are the sample preparation and unacceptable
variability in multiple measurements of the same sample. The
best way of preparing a sample, right dilution of the sample
used in the assay, and low coefficient of variation (CV) holds
importance in achieving accuracy. As of now there is no standard
protocol which can help to detect allergen proteins in peanut
seeds on the basis of dilution factor and low coefficient of
variation (CV). Further the genetic diversity available in peanut
germplasm has not yet been fully exploited and the accumulation
of favorable allelesmay provideminimum allergen proteins in the
improved peanut genotypes. At this juncture a highly sensitive,
easy to use and reliable protocol for peanut seeds is required to
screen various germplasm sets and breeding material. Therefore,
the present study focused on developing a robust protocol
to estimate major allergens in peanut seeds through ELISA
based methods.
MATERIALS AND METHODS
Plant Material, Reagents and Chemicals
A total of 38 peanut genotypes (see Supplementary Table 1)
were used while improving and standardizing the ELISA
protocol. The seeds of these genotypes after harvest were
stored at 10◦C and were taken out only when needed
for the experiment. ELISA components such as peanut
allergen standards, monoclonal antibodies (MAbs; primary and
secondary biotinylated antibody), and enzyme conjugates were
purchased from INDOOR Biotechnologies Inc. (Charlottesville,
VA, USA) for the estimation of five important peanut allergens
namely Ara h 1, Ara h 2 Ara h 3, Ara h 6, and Ara h 8.
These include monoclonal antibody 2C12 (clone 2C12 A11 A3)
and biotinylated antibody 2F7 (clone 2F7 C12 D10) for Ara h
1, the monoclonal antibody 1E8 and biotinylated monoclonal
antibody 4G9 for Ara h 3 while monoclonal antibody 3B8 (clone
3B8 B5) and biotinylated antibody 3E12 (clone 3E12 C4 B3)
for Ara h 6. Similarly, the monoclonal antibody 1C4 (clone
1C4 G4 C8) and a polyclonal rabbit anti Ara h 2 antibody
(AH2) for Ara h 2; capture antibody 4G6 and a polyclonal
antiserum raised in rabbit for Ara h 8 were purchased from
INDOOR Biotechnologies Inc. Conjugated Goat anti-Rabbit IgG
was purchased from Jacksons Laboratories (Bar Harbor, USA Cat
No. 111-036-046). ABTSTM (Cat No. 11204521001) and all other
reagents and chemicals were purchased from Sigma-Aldrich Co.
(Oakville, ON, Canada).
Allergen Standards and Enzyme Solution
Preparation
The allergen standards were purchased from INDOOR
Biotechnologies Inc. (Charlottesville, VA, USA). These standards
were isolated from lightly roasted peanut flour (Runner cultivar)
and purified by affinity chromatography. The purified standards
were supplied in phosphate buffer, received on the ice and
stored at −20◦C until further use. Purified natural Ara h 1
(Lot 39285; Conc. 20,000 ng/ml), Ara h 2 (Lot 39158; Conc.
2,500 ng/ml), Ara h 3 (Lot 39051; Conc. 1,250 ng/ml) Ara h
6 (Lot 39198; Conc. 1,000 ng/ml), and Ara h 8 (Lot 39033;
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TABLE 1 | The repeatability and precision of the ELISA-based assay in peanut seeds.
S. No Peanut genotype Range in peanut
seeds (µg/g)
Mean (µg/g) Standard
deviation (SD)
Range of (CV%) Mean of (CV%)
Ara h 1 ALLERGEN PROTEIN
1 ICG 311 66–89 77 12 3–5 4
2 ICG 4798 719–936 842 112 5–15 9
3 ICG 5494 1,638–1,689 1,652 23 2–4 3
4 ICG 7963 3,496–4,105 3,761 312 2–11 7
5 ICG 11457 7,493–8,589 8,073 551 3–7 5
6 ICG 13856 18,253–22,080 20,481 1,989 1–10 5
7 ICG 13858 39,058–46,106 42,609 3,524 2–7 14
8 ICG 15380 39,426–43,859 41,008 2,474 1–15 7
Ara h 2 ALLERGEN PROTEIN
9 ICG 311 253–361 307 54 22–25 24
10 ICG 532 208–331 265 62 12–19 16
11 ICG 12189 230–429 327 100 6–19 13
12 ICG 13491 5,005–6,062 5,426 561 5–17 10
13 ICG 7969 2,488–2,925 2,666 230 9–18 14
14 ICG 9777 2,390–2,467 2,422 41 1–15 7
15 ICG 9842 2,973–3,564 3,321 309 10–18 14
16 ICG 14705 4,136–4,642 4,432 264 4–17 11
Ara h 3 ALLERGEN PROTEIN
17 ICG 311 406–646 559 32 8–24 8
18 ICG 1487 369–392 382 12 6–9 8
19 ICG 3240 1,274–1,626 1,452 176 9–22 15
20 ICG 3343 5,044–5,679 5,385 320 0.15–19 11
21 ICG 12682 7,161–7,758 7,524 250 2–29 13
22 ICG 12879 12,029–13,195 12,676 593 8–24 17
23 ICG 13603 4,707–5,125 4,909 209 7–12 9
24 ICG 14482 5,731–6,491 6,009 419 7–23 14
Ara h 6 ALLERGEN PROTEIN
25 ICGV 01328 829–1,065 949 118 0.05–14 5
26 ICGV 87354 1,578–1,629 1,561 77 7–23 14
27 ICGV 93470 2,066–2,412 2,184 197 9–24 14
28 ICG 111 38,174–44,065 39,587 3,453 0.05–14 5
29 ICG 10036 29,711–32,982 31,731 1,809 4–15 10
30 ICGV 91116 41,288–45,998 43,375 1,947 5–11 8
Ara h 8 ALLERGEN PROTEIN
31 ICG 311 0.275–0.503 0.385 0.114 3–17 11
32 ICG 532 0.415–1 0.752 0.332 4–20 13
33 ICG 12189 0.956–1.302 1.374 0.458 7–12 10
34 ICG 13491 4.8–5.2 5 0.189 5–22 16
35 ICG 7969 5.2–6.3 5.9 0.585 8–23 17
36 ICG 9449 4.2–5.2 4.7 0.477 17–24 21
37 ICG 9842 4.7–5.3 4.9 0.347 5–21 15
38 ICG 14705 5.6–6 6 0.322 11–27 20
The range and mean of different allergen in selected Peanut genotypes. Data represents the mean of three replication ± SD and CV%.
Conc. 2,500 ng/ml) were used as allergen standards for each
assay. The standard concentration of each allergen ranged from
2000 - 4 ng/ml for Ara h 1, 250 - 0.5 ng/ml for Ara h 2, 125
- 0.24 ng/ml for Ara h 3, 100 - 0.2 ng/ml for Ara h 6 and 250
- 0.49 ng/ml for Ara h 8. ABTS Substrate is a water-soluble
peroxidase substrate that yields a measurable green end product
for use in ELISA methods. The ABTSTM (Sigma Aldrich Cat No.
11204521001) was dissolved in 1mM ABTS solution. The ABTS
solution contains 0.1M anhydrous citric acid and 0.2M Dibasic
Sodium phosphate.7H202. The 274mg ABTS
TM were dissolved
in 500ml ABTS solution and store in an amber color bottle at
4◦C until use.
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FIGURE 1 | Systematic diagram showing the protocol for allergen estimation in peanut seed through sandwich ELISA.
Development of Protocol for Allergen
Estimation
The ELISA is sandwich format having double-antibody based
on the specific interaction between antigen and antibody.
The peanut allergen proteins are sandwich between two
antibodies such as capture antibody and conjugated antibody
with streptavidin peroxidase (Figure 1). For color development
ABTSTM was used. The color intensity depends on the
concentration of allergen protein present in the specific sample
and measured with an iMark microplate reader (Bio-Rad) at
405 nm. The Microplate Manager (MPM) software was used
while analyzing the optical density values of standards and
samples. The systemic representation showed the key steps
involved to develop the ELISA protocol, to estimate the peanut
allergens through peanut seeds (Figure 1).
Grinding of Seeds, Homogenization and Purification
Sample extracts were prepared by grinding two grams of peanut
seeds in fine powder and then dissolved in 40ml of PBS-T (0.05%
Tween in phosphate buffered saline, pH 7.4) containing 1MNaCl
in 50ml falcon tubes (Sarstedt No:55.476). After 2 h of gentle
stirring on a rocking platform at room temperature, the aqueous
phase was collected by centrifugation at 2,500 rpm at 4◦C for
20min. The aqueous phase was subsequently centrifuged at 3,500
rpm for 10min at room temperature to remove residual traces
and insoluble particles. Protein extracts were stored at −20◦C
until use.
Dilution Factor for Different Peanut Allergens
Dilution of a sample extract is critical for an ELISA which in
turn determines the values of detection range for antibody and
target antigen concentrations. Subsequently, the concentration of
that specific allergens sample was estimated by multiplying the
concentration found from the graph by the dilution factor (36,
37). By using different dilutions, we estimated the detection range
of target antigen and antibody concentration. We standardized
the dilution factors to detect each allergen proteins presents in the
peanut seeds. Each sample was diluted in three different dilutions
to detect the allergic protein present in seeds. The major allergen
proteins such as Ara h 1 (1/1,000, 1/2,000, and 1/4,000), Ara h
2 (1/5,000, 1/10,000, and 1/20,000), Ara h 3 (1/5,000, 1/10,000,
and 1/20,000), and Ara h 6 (1/40,000, 1/80,000, and 1/160,000)
were diluted on a high range as compared to minor allergen
protein, Ara h 8, which was diluted in low dilution range (1/10,
1/20, and 1/40). The optimal concentration of HRP-conjugated
streptavidin was determined in the same way.
Steps Involved in ELISA
Antibody coating and blocking
Polystyrene microtiter plates (NUNC Maxisorp, Roskilde,
Denmark) were coated with 100 µL mAb at 10 µL /10ml
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in 50mM carbonate buffer (100 µL/well). After overnight
incubation at 4◦C, the coated wells were washed three times with
washing buffer (phosphate buffer containing 0.05% Tween 20)
and left to block with 1% BSA for 30min at room temperature
followed by three times washing with washing buffer.
Capture of allergen samples and standard
The standard and samples were diluted in washing buffer
containing 1% bovine serum albumin fraction V (Sigma Aldrich
Cat No. 10735086001). The standard of each allergen was
diluted to make 10 serial doubling dilutions in dilution buffer.
Subsequently, the allergen samples (100 µL/well) with three
different dilutions were added in respective wells and incubated
at room temperature for 1 h.
Adding of detection antibody in plate
After incubation plates were washed three times and specific
biotinylated anti Ara h mAb were diluted to 1/1,000 in washing
buffer containing BSA (1 mg/mL) was added to the wells (100
µL/well) and incubated for 1 h at room temperature.
Streptavidin-enzyme conjugate
After three washes, HRP-conjugated Streptavidin diluted to
1/1,000 in washing buffer containing BSA (1 mg/mL) was added
to the wells and incubated for 1 h at room temperature.
Addition of the substrate
The colorimetric substrate was added to the wells and which
formed a colored solution when catalyzed by the enzyme. The
wells were washed three times and 100 µL of 1mM ABTS
was added to each well. After 5min, the color development
was observed.
Detection through ELISA reader
The optical density (OD) was measured at 405 nm using BioRad
Microplate Reader and the data were processed using Microplate
Manager V 6.1 (Bio-Rad Laboratories).
Spike and Recovery Studies
To test the accuracy of peanut allergens estimation, known
amount of each allergen was spiked in the peanut extracts. The
spike standard concentration for each allergen was ranging from
100 to 1,600 ng/ml for Ara h 1, 25 to 200 ng/ml for Ara h 2,
and 6.25 to 100 ng/ml for Ara h 3, 10 to 160 for Ara h 3, and
from 10 to 100 ng/ml for Ara h 8. These known amounts of
individual standard (Ara h 1, Ara 2, Ara 3 Ara h 6, and Ara h
8) allergens were spiked in peanut extract and later calculating
their final content in extract. The recovery was calculated as (B–
C)/(A × 100), Where A = Known amount of peanut standard,
B = Concentration of spiked standard, C = Concentration of
peanut extract.
Statistical Analysis and Sample Analysis
Design
All experiments were conducted with three replications based on
dilution factor (DF). Mean ELISA plate reading values (Optical
Density; OD) for each standard and sample were used to plot a
standard curve by placing each allergen standard concentration
values on Y axis and respective OD values on X axis on an Excel
FIGURE 2 | Diagram showing 96-well plate design and the serial dilution of allergen standard and peanut samples in three replicates and three dilutions. The wells A1
to A10 and B1 to B10 contain serial dilution of specific allergen standard; A11 to A12 and B11 to B12 are blank; while the C, D, E, F, G, and H wells are with unknown
peanut samples in three different dilutions for specific allergen.
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FIGURE 3 | Standard curve and optimized dilutions for Ara h 1, Ara h 2, and Ara h 3 allergens in peanut seeds. (A) standard curve for Ara h 1 allergen and (B)
standardization of dilution factor to estimate Ara h 1. (C) standard curve for Ara h 2 allergen and (D) standardization of dilution factor to estimate Ara h 2. (E) standard
curve for Ara h 3 allergen, and (F) standardization of dilution factor to estimate Ara h 3.
spreadsheet on the computer. Using regression equation values,
we estimated specific allergen concentration in each sample. Data
are expressed as means ± standard deviation (SD). Allergen
standards and samples were placed in the 96- well format plate as
given in Figure 2. The statistical analysis of data was performed
using SigmaPlot 11.0.
RESULTS
Optimization of Dilution Factors (DFs) for
Different Allergens From Peanut Seeds
To find the concentration of the different types of unknown
allergens in the peanut seed samples, dilutions were performed
on the different scale for specific allergens so that the relative
concentrations fall according to their standard graph. Finally,
after the absorbance of the specific allergens was determined,
the concentrations of these specific allergens were determined
by finding the location on the graph that corresponds to the
absorbance of the standard. The concentrations of the allergens
sample were estimated by multiplying samples concentration
with dilution factor. For Ara h 1, the standard ranges from
0.004 to 2µg/mL (Figure 3A), while it ranged from 0.0005 to
0.25µg/mL and 0.00024 to 0.125µg/mL for Ara h 2 and Ara h
3 (Figures 3C,E), respectively. The standard graph range of Ara
h 6 and Ara h 8 was showing range between 0.0002 to 0.10µg/mL
and 0.0005 to 0.250µg/mL (Figures 4A,C).
Based on the standard graph, the dilution factor was optimized
on the basis of OD value and dilution of the peanut samples.
Each allergen protein was estimated at different dilution factors
(DF) in same samples. Here we used a number of dilutions in
the peanut samples to detect the specific allergic protein in seeds.
The Ara h 1 was detected on three serial doubling dilutions,
1:1,000, 1:2,000, and 1:4,000 (Figure 3B) while Ara h 2 and Ara
h 3 detected on same dilution 1: 5,000, 1:10,000, and 1: 20,000
(Figures 3D,F). In peanut seeds, the Ara h 6 was detected in
the high range (1:40,000, 1:80,000, and 1:160,000) dilution factor
Frontiers in Nutrition | www.frontiersin.org 6 June 2019 | Volume 6 | Article 68
Pandey et al. ELISA-Based Protocol for Peanut Allergens
FIGURE 4 | Standard curve and optimized dilutions for Ara h 6 and Ara h 8 allergens in peanut seeds. (A) standard curve for Ara h 6 allergen by sandwich ELISA, and
(B) standardization of dilution factor to estimate Ara h 6. (C) standard curve for Ara h 8 allergen by sandwich ELISA, and (D) standardization of dilution factor to
estimate Ara h 8.
(Figure 4B), while Ara h 8 detected in a low range of dilution
i.e., 1:10, 1:20, and 1:40 (Figure 4D). The result showed that in
1,000 dilution, the amount of Ara h 1 were detected 617 ng/ml
while in 4000 dilution it decreased upto 152 ng/ml (Figures 3B).
Likewise other peanut allergens Ara h 2, Ara h 3, Ara h 6, and Ara
h 8 also showing similar pattern in their optimized result. The
optimized dilution graphs (Figures 3D,F; 4B,D) showing that
when we increasing the dilution, peanut allergen concentration
is decreasing accordingly.
Allergens Estimation in Peanut Seeds
The specificity of the sandwich ELISA was investigated by testing
sample extracts of 38 peanut genotypes using different dilution
factors for different allergens. Here, we used a single sample
with three different dilutions and estimated four major (Ara
h 1, Ara h 2, Ara h 3, and Ara h 6) and one minor (Ara h
8) allergen proteins in peanut seeds using specific antibodies.
Supplementary Table 1 showed the selected genotypes on the
basis of minimum and themaximum amount of allergens present
in specific genotypes. The minimum and maximum amount of
Ara h 1 was detected in ICG 311 (12.5µg/g) and ICG 15380
(42733.87µg/g) genotypes. The low and high level of Ara h 2 was
detected in ICG 532 (22.2µg/g) and ICG 14482 (20600.3µg/g)
while ICG 311 (157.8µg/g) and ICG 12879 (14556.4µg/g)
showing low and high amount of Ara h 3, respectively. Genotype
ICG 3992 (5767.6µg/g) contained low amount of allergen while
ICGV 91116 (42317.6µg/g) contained high amount of Ara h
6 allergen among the genotypes. Ara h 8 showed low range of
allergen ranging from lowest in ICG 311(0.084µg/g) to highest
in ICG 14705 (6.8 µg/g).
Repeatability and Reproducibility
To validate the protocol, we repeated our experiments in three
technical replicates with three dilutions optimized for each
specific allergen. The assay had a linearity of r2 ranges from
0.987 to 0.999 for all the specific allergen concentration present
in peanut seeds. The coefficient of variation (CV) of each peanut
sample in triplicates was consistently <20% (Table 1). Assay
repeatability and reproducibility was <15% CV as measured by
using the three peanut samples (Table 1). We found that dilution
factor and CV are the key features of this protocol. This method
is fairly simple to estimate specific allergen protein present
in a single peanut seed. The validation experiments showed
linearity of the method and each specific allergen showing
different range in different peanut seeds. By using this protocol,
we identified wide range of specific allergens, Ara h 1 (77–
42,609µg/g) (Figure 5A, Table 1), Ara h 2 (265–5,426µg/g)
(Figure 5B, Table 1), Ara h 3 (382–12,676µg/g) (Figure 5C,
Table 1), Ara h 6 (949–43,375µg/g) (Figure 5D, Table 1), and
Ara h 8 (0.385–6 µg/g) (Figure 5E, Table 1) in peanut genotypes.
The accuracy of the developed method was determined by
performing the spike and recovery test. The mean recoveries
(n = 3) for all the five allergens, individually tested, were
in the range of 81–115% (Table 2). This indicates that the
developedmethod is accurate for all five peanut allergens through
peanut extract.
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FIGURE 5 | Assessment of the new protocol for its reproducibility for Ara h 1, Ara h 2, Ara h 3, Ara h 6 and Ara h 8 allergen proteins. (A) Ara h 1 allergen proteins, (B)
Ara h 2 allergen proteins, (C): Ara h 3 allergen proteins, (D): Ara h 6 allergen proteins and (E) Ara h 8 allergen protein. The figure shows variation in the presence of
allergen protein in low to high range in different peanut genotypes.
DISCUSSION
Peanut allergy is one of the major food allergies and leads to
death in case of severe allergenic reaction. In order to tackle this
problem, efforts toward the development of peanut varieties with
minimum or nil allergens needs to be initiated in addition to
efforts for developing cure for the allergy caused due to peanut
consumption. Peanut genetic improvement program for this
particular trait require a reliable, robust and cost-effective assay
to screen the large scale germplasm and breeding material for
major allergens. In this context, this article reports development
of a cost-effective and reliable ELISA-based protocol to estimate
five major allergens (Ara h 1, Ara h 2, Ara h 3, Ara h 6, and Ara h
8) in peanut seeds.
In serological tests, two-fold differences in measurements of
replicates of the same sample are considered as acceptable (38).
Current studies describe the standardization of dilution factor
for peanut seed sample to analyse the specific allergen protein
concentration through ELISA method. It has been observed that
the concentration and dilution factors are inverse means and
the concentration of the allergens decreased with the increasing
dilution of the samples. All major allergen proteins (Ara h 1,
Ara h 2, Ara h 3, Ara h 6, and Ara h 8) concentration was
gradually decreased while increasing the dilution. For instance,
the concentration of Ara h 1 was 617 ng/mL in 1,000 dilution,
and in 2,000 dilution the concentration of Ara h 1 was detected
as 296 ng/mL while in 4,000 dilution the concentration of Ara h 1
was detected as 152 ng/mL (Figure 3B). On the basis of optimized
dilution factors, major allergen proteins were estimated in peanut
seeds with increased precision. The results from our study show
the importance of standard curve and dilution as an important
parameter for quantifying the ELISA results (39). Dilution factor
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TABLE 2 | Recovery of five major allergens (Ara h 1, Ara h 2, Ara h 3, Ara h 6, and
Ara h 8) from artificial spiked peanut allergens through ELISA in peanut seeds.
S. No. Concentration
used for spiking
in samples
(ng/ml)
Detected
concentration of
spiked samples
(ng/ml)
% recovery of
allergen in
spiked samples
CV (%)
RECOVERY OF SPIKED Ara h 1 FROM SAMPLES
1 100 105 ± 9 105.3 21.6
2 200 206 ± 8 103.0 22.2
3 400 376 ± 7 94.0 6.3
4 800 786 ± 10.9 98.3 17.6
5 1,600 1562 ± 11 97.6 11.4
RECOVERY OF SPIKED Ara h 2 FROM SAMPLES
1 25 27 ± 3.2 106.8 10.9
2 50 57.9 ± 4.8 115.8 17.8
3 100 104.3 ± 0.3 104.4 12.8
4 150 148.7 ± 10.9 99.2 16.5
5 200 188.6 ± 7.6 94.3 20.7
RECOVERY OF SPIKED Ara h 3 FROM SAMPLES
1 6.25 5.7 ± 0.77 91.4 9.9
2 12.5 12.17 ± 5.9 97.4 19.0
3 25 20.34 ± 3.24 81.4 7.0
4 50 53.45 ± 5.25 106.9 10.1
5 100 108.96 ± 3.8 109.0 9.4
RECOVERY OF SPIKED Ara h 6 FROM SAMPLES
1 10 9.70 ± 2.9 97.0 15.5
2 20 17.94 ± 0.25 89.7 10.4
3 40 40.04 ± 4.31 100.1 14.8
4 80 83.97 ± 1.8 105.0 9.9
5 160 157.88 ± 4.37 98.6 8.9
RECOVERY OF SPIKED Ara h 8 FROM SAMPLES
1 1.25 1.26 ± 0.15 100.78 5.26
2 2.5 2.48 ± 0.05 99.26 20.31
3 5 4.93 ± 0.36 98.53 16.16
4 10 53.45 ± 5.25 105.62 11.58
5 20 108.96 ± 3.8 100.56 12.30
Each sample was spiked with known amount of peanut allergens in peanut extract. Data
represents the mean of three replicates ± SD and CV%. Formula used for detection (%
recovery)= (B–C)/A*100. Where A, Known amount of peanut standard; B, Concentration
of spiked standard; C, Concentration of peanut extract.
is an important step in ELISA before analyzing the results.
Dilution assay apprises the actual concentration would be taken
to experiment. To attained highly sensitive results for protein
concentration, optimum values for dilution assay would provide
a valid conclusion (39, 40). Earlier few attempts were made to
quantify the levels of allergens in peanut seed using immuno
assays and chromatography methods. But majority of them were
expressed only in terms of percentages out of total protein present
in the raw peanut seed. In one of the earlier studies, it was
concluded that quantification of a single protein is not possible
from a sample mixture of allergenic and non-allergenic proteins
(41). Later in another study, using human sera from patients with
documented history of peanut allergy, allergens from different
peanut introductions were quantified and expressed in terms of
ELISA optical density readings (4). In a recent study, Ara h 3
was quantified and found that it is the most abundant protein
followed by Ara h 1 and Ara h 2 (34). However, in our study,
Ara h 1 found in larger quantities followed by Ara h 6, Ara h 2,
Ara h 3, and Ara h 8. Extraction method and proper dilutions
of extracts plays crucial role in the precise quantification of these
allergen proteins. Here in our study, we have thoroughly studied
series of dilutions for each allergen and their impact on the
quantification of allergens. These results clearly indicate three
different dilutions for each major peanut allergen are required
for precise detection in peanut seeds. Further the suggested
96-well plate design can allow the analysis of 24 samples in
three replicates.
The newly developed ELISA protocol was validated on assay
linearity, accuracy, repeatability and reproducibility. On the basis
of primary results, few peanut genotypes were selected with
low, medium and higher range of allergen proteins present in
seeds. Our results indicated a different level of specific allergen
profiles among peanut genotypes. Marked differences in specific
peanut allergen profile were observed in peanut flour and peanut-
based products such as peanut butter and other confectionary
preparations for clinical use (42). In the serological assay, the
variability produces continuous value were summarized by the
coefficient of variation (CV), often reported in percentage (42,
43). The low CV observed in the current study while preparing
dilutions provided more confidence in results produced for
multiple genotypes using this protocol. Therefore, this protocol
can provide accurate estimation for targeted five allergens and
hence, can be very useful in accelerating the peanut research
leading to detection and development of hypo-allergic peanuts.
The sample value obtained from an ELISA is dependent
upon the interaction between the protein of interest and the
ELISA’s antibodies, and comparison of this interaction relative to
a recombinant protein standard curve. We have validated this
newly developed ELISA protocol for estimation of the major
peanut allergens in peanut seeds by conducting the recovery
experiments. The validation of ELISA protocol depends upon the
recovery experiment which allow for a well-ordered presentation
of the results (42).
CONCLUSIONS
This study reports successful development and validation of an
accurate ELISA method for allergen estimation in peanut seeds.
The method developed here is a simple, fast and cost-effective
method and can be applied to a large number of samples for
specific allergen estimation. Our results clearly indicates three
different dilutions for each major peanut allergen are required
for precise detection in peanut seeds. Further the suggested 96-
well plate design can allow the analysis of 24 samples in three
replicates. This protocol can be very useful in accelerating the
research in identifying peanut genotypes with minimum allergen
proteins. Furthermore, the high level of phenotypic variation in a
selected set of peanut germplasm showed very positive indication
and hope toward efforts of developing allergen-free peanut
genotypes in coming years using genomics-assisted breeding
including genome editing.
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